# North European Oil Royalty Trust: financial statements, quarterly

NRT · NYSE · CIK 72633 · [Financials](/sectors/financials.md) · fiscal year ends Oct 31

Pages: [Overview](/companies/nrt.md) · [Financials](/companies/nrt/financials.md) · [Filings](/companies/nrt/filings.md) · [Insiders](/companies/nrt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nrt/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-01-31) | period not labelled (2025-04-30) | period not labelled (2025-07-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [506](/filings/0001140361-26-007364.md) | [2,471](/filings/0001140361-26-024281.md) | [2,617](/filings/0001140361-26-035923.md) | [2,212](/filings/0001140361-26-007364.md) | [2,383](/filings/0001140361-26-024281.md) | [2,642](/filings/0001140361-26-035923.md) |
| Net income | $k | [285](/filings/0001140361-26-007364.md) | [2,261](/filings/0001140361-26-024281.md) | [2,459](/filings/0001140361-26-035923.md) | [1,945](/filings/0001140361-26-007364.md) | [2,052](/filings/0001140361-26-024281.md) | [2,474](/filings/0001140361-26-035923.md) |
| Basic EPS | $ per share | [0.03](/filings/0001140361-26-007364.md) | [0.25](/filings/0001140361-26-024281.md) | [0.27](/filings/0001140361-26-035923.md) | [0.21](/filings/0001140361-26-007364.md) | [0.22](/filings/0001140361-26-024281.md) | [0.27](/filings/0001140361-26-035923.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Cash and equivalents | $k | [4,785](/filings/0001140361-26-035923.md) | [3,881](/filings/0001140361-26-007364.md) | [3,911](/filings/0001140361-26-024281.md) | [4,363](/filings/0001140361-26-035923.md) |
| Total assets | $k | [4,785](/filings/0001140361-26-035923.md) | [3,881](/filings/0001140361-26-007364.md) | [3,911](/filings/0001140361-26-024281.md) | [4,363](/filings/0001140361-26-035923.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets

Shares outstanding: 9,190,590 at 2026-07-31, from the cover of the [10-Q filed 2026-09-08](/filings/0001140361-26-035923.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.